Broparestrol

Broparestrol
Clinical data
Trade names	Acnestrol, Longestrol
Other names	LN-107; α-Bromo-α,β-diphenyl-β-p-ethylphenylethylene; BDPE
Pregnancy; category	X (Contraindicated);
Routes of; administration	By mouth
Drug class	Selective estrogen receptor modulator
Legal status
Legal status	In general: ℞ (Prescription only);
Identifiers
	IUPAC name 1-(2-bromo-1,2-diphenylethenyl)-4-ethylbenzene;
CAS Number	479-68-5; Z-isomer: 22393-63-1;
PubChem CID	3032769;
ChemSpider	2297663;
UNII	4F4UXV47YI; Z-isomer: D6CYJ2NI2L;
CompTox Dashboard (EPA)	DTXSID201203500 ;
Chemical and physical data
Formula	C22H19Br
Molar mass	363.298 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CCc1ccc(cc1)/C(=C(\c2ccccc2)/Br)/c3ccccc3;
	InChI InChI=1S/C22H19Br/c1-2-17-13-15-19(16-14-17)21(18-9-5-3-6-10-18)22(23)20-11-7-4-8-12-20/h3-16H,2H2,1H3/b22-21+; Key:OQCYTSHIQNPJIC-QURGRASLSA-N;

Broparestrol (INNTooltip International Nonproprietary Name) (brand names Acnestrol, Longestrol; former developmental code name LN-107), also known as α-bromo-α,β-diphenyl-β-p-ethylphenylethylene (BDPE), is a synthetic, nonsteroidal selective estrogen receptor modulator (SERM) of the triphenylethylene group^[1] that has been used in Europe as a dermatological agent and for the treatment of breast cancer.^[2]^[3]^[4]^[5]^[6] The drug is described as slightly estrogenic^[7] and potently antiestrogenic,^[8]^[9] and inhibits mammary gland development and suppresses prolactin levels in animals.^[10] It is structurally related to clomifene and diethylstilbestrol.^[6]^[10] Broparestrol is a mixture of E- and Z- isomers (LN-1643 and LN-2299, respectively), both of which are active, and are similarly antiestrogenic but, unlike broparestrol, were never marketed.^[2]

References

^ Hospital M, Busetta B, Courseille C, Precigoux G (1975). "X-ray conformation of some estrogens and their binding to uterine receptors". Journal of Steroid Biochemistry. 6 (3–4): 221–5. doi:10.1016/0022-4731(75)90136-3. PMID 171486.
^ ^a ^b Elks J (14 November 2014). "Broparestrol". The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 183–. ISBN 978-1-4757-2085-3.
^ Milne GW (8 May 2018). "Broparestrol". Drugs: Synonyms and Properties: Synonyms and Properties. Taylor & Francis. pp. 1401–1402. ISBN 978-1-351-78989-9.
^ "Broparestrol". Index Nominum 2000: International Drug Directory. Taylor & Francis. January 2000. pp. 139–. ISBN 978-3-88763-075-1.
^ Muller (19 June 1998). European Drug Index: European Drug Registrations (Fourth ed.). CRC Press. pp. 23–. ISBN 978-3-7692-2114-5.
^ ^a ^b Morton IK, Hall JM (6 December 2012). Concise Dictionary of Pharmacological Agents: Properties and Synonyms. Springer Science & Business Media. pp. 56–. ISBN 978-94-011-4439-1.
^ Villee CA, Hagerman DD (April 1957). "Compounds with antiestrogenic activity in vitro". Endocrinology. 60 (4): 552–558. doi:10.1210/endo-60-4-552. PMID 13414683.
^ Al-Hassan, Mohammed I. (1987). "Synthesis of broparestrol using palladium-catalyzed cross-coupling". Journal of Organometallic Chemistry. 321 (1): 119–121. doi:10.1016/0022-328X(87)80330-3. ISSN 0022-328X.
^ Magarian RA, Overacre LB, Singh S, Meyer KL (1994). "The medicinal chemistry of nonsteroidal antiestrogens: a review". Current Medicinal Chemistry. 1: 61-104 (95). doi:10.2174/0929867301666220210212635. S2CID 89392480.
^ ^a ^b Drosdowsky M, Edery M, Guggiari M, Montes-Rendon A, Rudali G, Vives C (May 1980). "Inhibition of prolactin-induced mammary cancer in C3Hf (XVII) mice with the trans isomer of bromotriphenylethylene". Cancer Research. 40 (5): 1674–1679. PMID 6245799.

This drug article relating to the genito-urinary system is a stub. You can help Wikipedia by expanding it.

[Hospital_1975-1] Hospital M, Busetta B, Courseille C, Precigoux G (1975). "X-ray conformation of some estrogens and their binding to uterine receptors". Journal of Steroid Biochemistry. 6 (3–4): 221–5. doi:10.1016/0022-4731(75)90136-3. PMID 171486.

[Elks2014-2] Elks J (14 November 2014). "Broparestrol". The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 183–. ISBN 978-1-4757-2085-3.

[Milne2018-3] Milne GW (8 May 2018). "Broparestrol". Drugs: Synonyms and Properties: Synonyms and Properties. Taylor & Francis. pp. 1401–1402. ISBN 978-1-351-78989-9.

[IndexNominum2000-4] "Broparestrol". Index Nominum 2000: International Drug Directory. Taylor & Francis. January 2000. pp. 139–. ISBN 978-3-88763-075-1.

[Muller1998-5] Muller (19 June 1998). European Drug Index: European Drug Registrations (Fourth ed.). CRC Press. pp. 23–. ISBN 978-3-7692-2114-5.

[MortonHall2012-6] Morton IK, Hall JM (6 December 2012). Concise Dictionary of Pharmacological Agents: Properties and Synonyms. Springer Science & Business Media. pp. 56–. ISBN 978-94-011-4439-1.

[VilleeHagerman1957-7] Villee CA, Hagerman DD (April 1957). "Compounds with antiestrogenic activity in vitro". Endocrinology. 60 (4): 552–558. doi:10.1210/endo-60-4-552. PMID 13414683.

[Al-Hassan1987-8] Al-Hassan, Mohammed I. (1987). "Synthesis of broparestrol using palladium-catalyzed cross-coupling". Journal of Organometallic Chemistry. 321 (1): 119–121. doi:10.1016/0022-328X(87)80330-3. ISSN 0022-328X.

[Publishers1994-9] Magarian RA, Overacre LB, Singh S, Meyer KL (1994). "The medicinal chemistry of nonsteroidal antiestrogens: a review". Current Medicinal Chemistry. 1: 61-104 (95). doi:10.2174/0929867301666220210212635. S2CID 89392480.

[pmid6245799-10] Drosdowsky M, Edery M, Guggiari M, Montes-Rendon A, Rudali G, Vives C (May 1980). "Inhibition of prolactin-induced mammary cancer in C3Hf (XVII) mice with the trans isomer of bromotriphenylethylene". Cancer Research. 40 (5): 1674–1679. PMID 6245799.

[1]

[2]

[3]

[4]

[5]

[6]

[7]

[8]

[9]

[10]

Broparestrol

See also

References